Form 4 for XYL Xylem Inc.
Accepted 2025-03-06 00:00:00 ET · period of report 2025-03-05 · accession 0001562180-25-002144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-06 | 2025-03-05 | XYL | Emmerich Meredith | SVP, Pres, AW | A - Grant | $129.67 | +1,060 | 4,833 | +28% | +$137.5K |
| D | 2025-03-06 | 2025-03-05 | XYL | Emmerich Meredith | SVP, Pres, AW | A - Grant | $129.67 | +3,721 | 3,721 | New | +$482.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | A | A | 1,060 | $129.67 | 4,833 | D | — | — | (F1) Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028. (F2) Includes additional shares due to dividend reinvestment. |
| 2 | Derivative | Non-Qualified Stock Options (Right to buy) | 2025-03-05 | A | A | 3,721 | $129.67 | 3,721 | D | $129.67 · — to 2035-03-05 | 3,721 Common Stock | (F3) Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028. |